Vitality Watch

⚠ Evidence note: Exercise has the strongest human evidence base in this vault, but protocol-level specifics are far less settled than the headline benefit.

Mentioned 43× · first seen 04-oct-2026 · last seen 16-nov-2026

Sarcopenic Obesity

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

pubmed meta analysis
Weight, Fat Mass, and Lean Mass Changes After Bariatric Surgery and GLP-1-Based Therapy: A Systematic Review and Meta-Analysis.
13-nov-2026 novelty 3 per-area 2 mentions
pubmed observational
Associations of short and long sleep duration with multiple adverse health outcomes among ageing adults in South Africa.
13-nov-2026 novelty 2 per-area 2 strengthens
pubmed review expert-opinion
Will sarcopenia preventative pharmacology ensure the long-term success of GLP-1-derived therapies?
12-nov-2026 novelty 3 per-area 3 strengthens
pubmed trial early human-rct
Trevogrumab (anti-GDF8) with or without garetosmab (anti-activin A) for prevention of muscle loss during semaglutide-induced weight reduction in people with obesity (COURAGE): a two-part, phase 2, double-blind, placebo-controlled, randomised trial.
11-nov-2026 novelty 4 per-area 4 strengthens
pubmed trial early human-rct
Effects of henagliflozin proline tablets versus metformin extended-release tablets on body composition in geriatric patients with newly diagnosed type 2 diabetes mellitus (HABIT-GEMs): study protocol for a multicentre, randomised, open-label trial.
11-nov-2026 novelty 3 per-area 3 strengthens
pubmed observational human-observational
Associations between sarcopenic obesity subtypes, cognitive function and neurodegenerative diseases risk in middle-aged and older adults.
10-nov-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
Nutrition Care Strategies at the Intersection of Menopause and Obesity Pharmacotherapy.
10-nov-2026 novelty 3 per-area 3 strengthens
pubmed review
Body recomposition in adults: mechanisms, modulators, and practical algorithms for simultaneous skeletal muscle mass gain and fat mass loss.
10-nov-2026 novelty 2 per-area 2 strengthens
clinicaltrials observational
Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients
10-nov-2026 novelty 2 per-area 2 mentions
clinicaltrials trial early expert-opinion
Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes
09-nov-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
Weaker or Just Lighter? Monitoring Strength and Function, Not Just Lean Mass, During GLP-1 Weight Loss.
08-nov-2026 novelty 3 per-area 3 strengthens
pubmed preclinical mechanism-plausible
GLP-1 and GIP receptor agonism does not directly drive skeletal muscle atrophy or impair myogenesis in primary human myotubes.
04-nov-2026 novelty 3 per-area 3 strengthens
pubmed review human-observational
Longitudinal associations between the hallmarks of aging and body composition: a narrative review.
04-nov-2026 novelty 3 per-area 3 strengthens
pubmed observational human-observational
Impact of sarcopenic obesity phenotype on long-term survival in geriatric trauma: A nationwide cohort study using weight-adjusted waist index.
03-nov-2026 novelty 3 per-area 3 strengthens
pubmed observational
Height, Weight, and BMI Muscle Mass Adjustment for Sarcopenic Obesity: Differential Associations with Functional Outcomes among Healthy Asian Older Adults.
02-nov-2026 novelty 2 per-area 2 strengthens
pubmed observational human-observational
Discordance Between Height- and BMI-Adjusted AWGS 2025 Definitions of Confirmed Sarcopenia After Stroke.
01-nov-2026 novelty 3 per-area 3 strengthens
pubmed observational
Possible sarcopenia, abdominal obesity, and all-cause mortality in middle-aged and older adults with chronic kidney disease: a dual-cohort study.
01-nov-2026 novelty 2 per-area 2 weakens
pubmed preclinical animal-model
Metabolic exhaustion underlies sarcopenic obesity susceptibility in aging mice as revealed by multi-omics factor analysis.
29-oct-2026 novelty 3 per-area 3 strengthens
pubmed review expert-opinion
Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient-Centered Prescribing.
29-oct-2026 novelty 3 per-area 3 strengthens
pubmed other
Corrigendum to "Effect of aerobic or resistance exercise, or both on insulin secretion, ciliary neurotrophic factor, and insulin-like growth factor-1 in dieting older adults with obesity" [Clin Nutr 51 (2025) 50-62].
28-oct-2026 novelty 1 per-area 1 mentions
pubmed observational
Differences in functional mobility and body composition between older Thai women with and without mild cognitive impairment: a cross-sectional comparative study.
27-oct-2026 novelty 2 per-area 2 strengthens
pubmed review
The use of glucagon-like peptide-1 agonists as a treatment for obesity in older people: risks and benefits.
27-oct-2026 novelty 2 per-area 2 strengthens
pubmed review expert-opinion
Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine.
26-oct-2026 novelty 3 per-area 3 strengthens
pubmed observational
Exploring Association Rules for Chronic Comorbidities in Possible Sarcopenic Obesity among Middle-aged and Older Adults: Evidence from the CHARLS 2015.
21-oct-2026 novelty 2 per-area 2 strengthens
pubmed observational
Relative muscle mass and grip strength as complementary correlates of metabolic syndrome: a nationwide DXA-based study of Korean adults.
17-oct-2026 novelty 2 per-area 2 strengthens
pubmed review
Glucose-Lowering Therapies in Type 2 Diabetes-Associated Sarcopenia: Mechanisms, Clinical Evidence and a Muscle-Centred Framework.
17-oct-2026 novelty 3 per-area 3 strengthens
pubmed observational human-observational
Combined impact of dynapenic abdominal obesity on stroke risk in middle-aged and older adults: evidence from two nationwide prospective cohorts.
15-oct-2026 novelty 3 per-area 3 strengthens
pubmed preclinical
Body Composition, Physical Activity and Energy Requirements Estimated Using Two Isotopic Methods in Old and Adult Beagle Dogs.
13-oct-2026 novelty 2 per-area 2 strengthens
pubmed observational
Prevalence and impact of sarcopenic obesity at hospital admission according to ESPEN-EASO approach on functional status of older adults: results of a retrospective and prospective observational study.
10-oct-2026 novelty 2 per-area 3 strengthens
pubmed observational
[Sarcopenia, obesity, and limitations in daily activities in older adults from Elsi-Brazil: recommendations from the Sarcopenia Definition and Outcomes Consortium].
09-oct-2026 novelty 2 per-area 2 strengthens
pubmed observational
Triglyceride-related metabolic indices and low relative muscle mass: a cross-sectional analysis of SMILE and NHANES.
07-oct-2026 novelty 2 per-area 2 strengthens
pubmed review
Digital Health Interventions for Weight Management in Older Adults with Overweight or Obesity: A Scoping Review.
07-oct-2026 novelty 2 per-area 2 strengthens
pubmed review
Optimizing health outcomes for older adults with sarcopenic obesity: a scoping review of nutrition, exercise and combined interventions.
07-oct-2026 novelty 2 per-area 2 strengthens
pubmed observational human-observational
Body composition changes in patients on GLP-1 receptor agonists undergoing an intensive cardiac rehabilitation program.
01-oct-2026 novelty 3 per-area 3 strengthens
pubmed observational
Association between anthropometric indices and serum liver enzyme levels in Iranian older adults: A cross-sectional study based on the Neyshabur Longitudinal Study on Ageing (NeLSA).
01-oct-2026 novelty 2 per-area 2 strengthens
pubmed observational human-observational
Consensus-Defined Sarcopenic Obesity and a Related Dynapenic Obesity Phenotype in Relation to Early Cognitive Impairment.
01-oct-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Loss ofdisrupts lipid signaling and causes slow muscle fiber degeneration.
28-sep-2026 novelty 3 per-area 3 strengthens
pubmed observational human-observational
Impact of the Updated Asian Working Group for Sarcopenia 2025 Criteria on the Prevalence and Clinical Characteristics of Sarcopenic Obesity in Older Patients With Heart Failure.
01-sep-2026 novelty 3 per-area 3 strengthens
pubmed review
Reframing obesity in aging people with HIV: sarcopenic obesity, muscle quality, and frailty.
01-sep-2026 novelty 2 per-area 2 strengthens
pubmed review
Risk of protein intake deficiency during treatment with GLP-1 and GIP/GLP-1 receptor agonists: considerations for secondary sarcopenia.
22-aug-2026 novelty 2 per-area 2 strengthens
pubmed review
Aging-, obesity-, and diabetes-related sarcopenia: Pathogenesis and interventions.
20-aug-2026 novelty 2 per-area 2 strengthens
pubmed observational human-observational
Dynapenic obesity and incident cross-domain multimorbidity: A prospective study of three ageing cohorts.
16-aug-2026 novelty 3 per-area 3 strengthens
pubmed review
Beyond Weight Loss: A Geriatric Perspective on GLP-1 RAs in Older Adults With Obesity.
04-jun-2026 novelty 2 per-area 2 mentions

build build 880 · 2bcef25 · 2026-11-18